We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Advanced Melanoma

Journal Scan / Research · May 11, 2022

Response to Immune Checkpoint Inhibitors in Acral Melanoma

European Journal of Cancer


Additional Info

European Journal of Cancer
Response to immune checkpoint inhibitors in acral melanoma: A nationwide cohort study
Eur. J. Cancer 2022 May 01;167(2022)70-80, OJ van Not, MM de Meza, AJM van den Eertwegh, JB Haanen, CU Blank, MJB Aarts, FWPJ van den Berkmortel, J van Breeschoten, JB de Groot, GAP Hospers, RK Ismail, E Kapiteijn, D Piersma, RS van Rijn, MAM Stevense-den Boer, AAM van der Veldt, G Vreugdenhil, HJ Bonenkamp, MJ Boers-Sonderen, WAM Blokx, MWJM Wouters, KPM Suijkerbuijk

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading